Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Effects of Treating Obstructive Sleep Apnea in Epilepsy

Study:

Effects of Treating Obstructive Sleep Apnea in Epilepsy

Rationale:

n/a

Purpose:

The purpose of this trial is to work out design issues prior to conducting a definitive phase 3 trial to determine whether treating sleep-related breathing disorders in people with epilepsy results in improvement in seizure control or an improvement in alertness during the day.

Study Status: Completed

Recruiting:
n/a

Condition Intervention Phase
Epilepsy
Sleep Apnea
Obstructive Sleep Apnea
Device: continuous positive airway pressure (CPAP)
Device: Placebo-CPAP
Phase 2

Verified by Vanderbilt University March, 2011

Sponsored by: Vanderbilt University
Information provided by: Vanderbilt University
ClinicalTrials.gov identifier: NCT00047463

Study Type: Interventional

Study Design: Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Cleveland Clinic Foundation
Cleveland, Ohio 44195
United States

Beth Malow, M.D., M.S.., Principal Investigator

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site